Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study
Description
SARS-CoV-2 vaccination is strongly recommended, particularly for fragile patients such as those undergoing active oncological treatments. It is crucial to conduct post-marketing surveillance in this patient population. In our study, we conducted a
